Assertio Holdings Inc Q3 2024 Everything You Need to Know Ahead of Earnings
ASRT Stock | USD 1.00 0.02 1.96% |
Slightly above 51% of Assertio Therapeutics' investor base is interested to short. The analysis of overall sentiment of trading Assertio Therapeutics stock suggests that many investors are impartial at this time. Assertio Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Assertio Therapeutics' earnings reports, geopolitical events, and overall market trends.
Assertio |
Assertio Holdings Inc is set to release its Q3 2024 earnings on Nov 11, 2024. The consensus estimate for Q3 2024 revenue is 28.87 million, and the earni
Read at gurufocus.com
Assertio Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Assertio Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Assertio Therapeutics Fundamental Analysis
We analyze Assertio Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Assertio Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Assertio Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Assertio Therapeutics is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Assertio Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Assertio Therapeutics stock to make a market-neutral strategy. Peer analysis of Assertio Therapeutics could also be used in its relative valuation, which is a method of valuing Assertio Therapeutics by comparing valuation metrics with similar companies.
Peers
Assertio Therapeutics Related Equities
CNTB | Connect Biopharma | 2.78 | ||||
ENTA | Enanta Pharmaceuticals | 2.22 | ||||
CRNX | Crinetics Pharmaceuticals | 1.39 | ||||
FOLD | Amicus Therapeutics | 1.71 | ||||
LGND | Ligand Pharmaceuticals | 2.26 | ||||
DSGN | Design Therapeutics | 4.62 | ||||
ORIC | Oric Pharmaceuticals | 5.60 | ||||
LYEL | Lyell Immunopharma | 6.00 | ||||
RVMD | Revolution Medicines | 6.89 | ||||
PASG | Passage Bio | 11.88 |
Additional Tools for Assertio Stock Analysis
When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.